Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription Articles published in Atherosclerosis Retrieve available abstracts of 221 articles: HTML format

Single Articles

March 2021
1. KUMAR A, Giannopoulos AA, Chatzizisis YS
   The stenotic vulnerable plaque: Identifying the substrate of acute coronary syndromes.
   Atherosclerosis. 2021;320:95-97.
   PubMed    
   
   
   February 2021
2. KISANUKI K, Muraki I, Yamagishi K, Kokubo Y, et al
   Weight change during middle age and risk of stroke and coronary heart disease: The Japan Public Health Center-based Prospective Study.
   Atherosclerosis. 2021;322:67-73.
   PubMed     Abstract available
   
   
   
3. CALIGIURI G, Mallat Z
   "Plaque erosion" or the danger of eerily quiet appearance.
   Atherosclerosis. 2021;318:43-44.
   PubMed    
   
   
   
4. SATO Y, Finn AV, Virmani R
   Calcified nodule: A rare but important cause of acute coronary syndrome with worse clinical outcomes.
   Atherosclerosis. 2021;318:40-42.
   PubMed    
   
   
   
5. RAGGI P, Abele J
   Molecular imaging for risk prediction of coronary artery disease: A close or far fetched option?
   Atherosclerosis. 2021;319:118-120.
   PubMed    
   
   
   January 2021
6. OHGAKU A, Fukamachi D, Takahashi K, Tamiya R, et al
   Absence of coronary angioscopy-derived in-stent thrombi is associated with major bleeding events in acute myocardial infarction.
   Atherosclerosis. 2021;319:62-71.
   PubMed     Abstract available
   
   
   
7. GERMAN CA, Shapiro MD
   Statins and coronary artery calcium: What's the score?
   Atherosclerosis. 2021;316:71-72.
   PubMed    
   
   
   
8. AUER J, Auer L
   Stent selection in patients with NSTEMI and risk of incident heart failure.
   Atherosclerosis. 2021;316:66-68.
   PubMed    
   
   
   December 2020
9. SVENDSEN K, Krogh HW, Igland J, Tell GS, et al
   2.5-fold increased risk of recurrent acute myocardial infarction with familial hypercholesterolemia.
   Atherosclerosis. 2020;319:28-34.
   PubMed     Abstract available
   
   
   
10. PURSNANI S, Merchant M
    South Asian ethnicity as a risk factor for coronary heart disease.
    Atherosclerosis. 2020;315:126-130.
    PubMed     Abstract available
    
    
    
11. OORNI K, Jauhiainen M, Kovanen PT
    Why and how increased plasma ceramides predict future cardiovascular events?
    Atherosclerosis. 2020;314:71-73.
    PubMed    
    
    
    
12. GUPTA M
    Addressing atherosclerotic cardiovascular disease risk in South Asians: A daunting task ahead.
    Atherosclerosis. 2020;315:76-78.
    PubMed    
    
    
    November 2020
13. KEDHI E, Delewi R, Fabris E, De Luca G, et al
    Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials.
    Atherosclerosis. 2020;315:55-61.
    PubMed     Abstract available
    
    
    October 2020
14. LIN CF, Chang YH, Yu FC, Tsai CT, et al
    Risk of heart failure following drug-eluting stent implantation in patients with non-ST-elevation myocardial infarction.
    Atherosclerosis. 2020 Oct 10. pii: S0021-9150(20)30575.
    PubMed     Abstract available
    
    
    
15. GAMBARDELLA J, Wang X, Mone P, Khondkar W, et al
    Genetics of adrenergic signaling drives coronary artery calcification.
    Atherosclerosis. 2020;310:88-90.
    PubMed    
    
    
    
16. VAN ROSENDAEL AR, Cainzos-Achirica M, Al-Mallah MH
    Calcified plaque morphology, density, and risk.
    Atherosclerosis. 2020;311:100-102.
    PubMed    
    
    
    September 2020
17. CHALIKIAS G, Serif L, Thomaidis A, Lantzouraki A, et al
    Comparison of novel LDL cholesterol equations in myocardial infarction patients: Clinical impact on risk re-classification and lipid treatment goals on secondary prevention.
    Atherosclerosis. 2020;313:96-101.
    PubMed     Abstract available
    
    
    
18. LIU X, Wu S, Song Q, Wang X, et al
    Visit-to-visit variability of lipid measurements and the risk of myocardial infarction and all-cause mortality: A prospective cohort study.
    Atherosclerosis. 2020 Sep 9. pii: S0021-9150(20)30493.
    PubMed     Abstract available
    
    
    
19. ZHANG M, Liu HH, Jin JL, Yan XN, et al
    Lipoprotein(a) and cardiovascular death in oldest-old (>/=80 years) patients with acute myocardial infarction: A prospective cohort study.
    Atherosclerosis. 2020;312:54-59.
    PubMed     Abstract available
    
    
    
20. LANGSTED A, Bojesen SE, Stroes ESG, Nordestgaard BG, et al
    AHRR hypomethylation as an epigenetic marker of smoking history predicts risk of myocardial infarction in former smokers.
    Atherosclerosis. 2020;312:8-15.
    PubMed     Abstract available
    
    
    
21. MAJEED K, Hillis GS, Schultz CJ
    A "light based biopsy" for high-risk atherosclerotic plaque.
    Atherosclerosis. 2020;309:65-66.
    PubMed    
    
    
    
22. BARTON DE, Hamilos M, Chatzizisis YS
    Left main percutaneous coronary intervention versus coronary artery bypass surgery: A case of true equivalence in low and intermediate complexity anatomy or a question yet to be answered?
    Atherosclerosis. 2020;308:45-47.
    PubMed    
    
    
    August 2020
23. SHITOLE SG, Kuniholm MH, Hanna DB, Boucher T, et al
    Association of human immunodeficiency virus and hepatitis C virus infection with long-term outcomes post-ST segment elevation myocardial infarction in a disadvantaged urban community.
    Atherosclerosis. 2020;311:60-66.
    PubMed     Abstract available
    
    
    
24. BELLASI A, Di Lullo L, Raggi P
    Is peritoneal dialysis superior to hemodialysis as far as cardiovascular risk? Another unsolved dilemma for maintenance dialysis.
    Atherosclerosis. 2020;307:75-77.
    PubMed    
    
    
    July 2020
25. CHATZIZISIS YS, Gajanan G, Bhatt DL, Dangas G, et al
    Management of acute myocardial injury in patients with confirmed or suspected COVID-19.
    Atherosclerosis. 2020;305:58-60.
    PubMed    
    
    
    June 2020
26. MARK L, Janosi A, Ferenci T, Toth PP, et al
    Recommendations of statin treatment after acute coronary syndrome: Hungarian experiences.
    Atherosclerosis. 2020;303:53-54.
    PubMed    
    
    
    May 2020
27. SUN CY, Li CY, Sung JM, Cheng YY, et al
    A comparison of the risk of acute myocardial infarction in patients receiving hemodialysis and peritoneal dialysis: A population-based, propensity score-matched cohort study.
    Atherosclerosis. 2020 May 29. pii: S0021-9150(20)30278.
    PubMed     Abstract available
    
    
    
28. SENONER T, Plank F, Barbieri F, Beyer C, et al
    Added value of high-risk plaque criteria by coronary CTA for prediction of long-term outcomes.
    Atherosclerosis. 2020;300:26-33.
    PubMed     Abstract available
    
    
    
29. DE NISCO G, Hoogendoorn A, Chiastra C, Gallo D, et al
    The impact of helical flow on coronary atherosclerotic plaque development.
    Atherosclerosis. 2020;300:39-46.
    PubMed     Abstract available
    
    
    April 2020
30. TOYA T, Corban MT, Imamura K, Bois JP, et al
    Coronary perivascular epicardial adipose tissue and major adverse cardiovascular events after ST segment-elevation myocardial infarction.
    Atherosclerosis. 2020;302:27-35.
    PubMed     Abstract available
    
    
    
31. PAN W, Sun M, Wu J, Dong H, et al
    Relationship between elevated plasma ceramides and plaque rupture in patients with ST-segment elevation myocardial infarction.
    Atherosclerosis. 2020;302:8-14.
    PubMed     Abstract available
    
    
    
32. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Culprit-only versus multivessel or complete versus incomplete revascularization in patients with non-ST-segment elevation myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention using newer-generation
    Atherosclerosis. 2020;301:54-64.
    PubMed     Abstract available
    
    
    
33. TIAN X, Zuo Y, Chen S, Li H, et al
    Association of changes in lipids with risk of myocardial infarction among people without lipid-lowering therapy.
    Atherosclerosis. 2020;301:69-78.
    PubMed     Abstract available
    
    
    
34. FRIKKE-SCHMIDT R
    HDL cholesterol and apolipoprotein A-I concentrations and risk of atherosclerotic cardiovascular disease: Human genetics to unravel causality.
    Atherosclerosis. 2020;299:53-55.
    PubMed    
    
    
    
35. CHEN Q, Li Q, Li D, Chen X, et al
    Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease.
    Atherosclerosis. 2020;299:45-52.
    PubMed     Abstract available
    
    
    
36. KARJALAINEN MK, Holmes MV, Wang Q, Anufrieva O, et al
    Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study.
    Atherosclerosis. 2020;299:56-63.
    PubMed     Abstract available
    
    
    March 2020
37. LI B, Luo YR, Tian F, Chen YD, et al
    Sitagliptin attenuates the progression of coronary atherosclerosis in patients with coronary disease and type 2 diabetes.
    Atherosclerosis. 2020;300:10-18.
    PubMed     Abstract available
    
    
    
38. OLSON NC, Sitlani CM, Doyle MF, Huber SA, et al
    Innate and adaptive immune cell subsets as risk factors for coronary heart disease in two population-based cohorts.
    Atherosclerosis. 2020 Mar 16. pii: S0021-9150(20)30147.
    PubMed     Abstract available
    
    
    
39. LI CK, Xu Z, Ho J, Lakhani I, et al
    Association of NPAC score with survival after acute myocardial infarction.
    Atherosclerosis. 2020;301:30-36.
    PubMed     Abstract available
    
    
    
40. PANG J, Abraham A, Vargas-Garcia C, Bates TR, et al
    An age-matched computed tomography angiographic study of coronary atherosclerotic plaques in patients with familial hypercholesterolaemia.
    Atherosclerosis. 2020;298:52-57.
    PubMed     Abstract available
    
    
    
41. CURE E, Cumhur Cure M
    Comment on: "High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment".
    Atherosclerosis. 2020;296:2-3.
    PubMed    
    
    
    
42. MORELLI MB, Santulli G, Gambardella J
    Calcium supplements: Good for the bone, bad for the heart? A systematic updated appraisal.
    Atherosclerosis. 2020;296:68-73.
    PubMed    
    
    
    
43. MAZIDI M, Katsiki N, Mikhailidis DP, Banach M, et al
    Associations of serum uric acid with total and cause-specific mortality: Findings from individuals and pooling prospective studies.
    Atherosclerosis. 2020;296:49-58.
    PubMed     Abstract available
    
    
    
44. ADINOLFI LE, Petta S, Fracanzani AL, Coppola C, et al
    Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study.
    Atherosclerosis. 2020;296:40-47.
    PubMed     Abstract available
    
    
    
45. SIMONETTO C, Heier M, Rospleszcz S, Meisinger C, et al
    Risk for cardiovascular events responds nonlinearly to carotid intima-media thickness in the KORA F4 study.
    Atherosclerosis. 2020;296:32-39.
    PubMed     Abstract available
    
    
    
46. ANZIC DROFENIK A, Vrtovec M, Bozic Mijovski M, Sever M, et al
    Progression of coronary calcium burden and carotid stiffness in patients with essential thrombocythemia associated with JAK2 V617F mutation.
    Atherosclerosis. 2020;296:25-31.
    PubMed     Abstract available
    
    
    
47. LESKELA RL, Torvinen A, Rissanen TT, Virtanen V, et al
    Outcomes of lipid control in secondary prevention of coronary artery disease in Finland: A 24-month follow-up after acute coronary syndrome.
    Atherosclerosis. 2020;296:4-10.
    PubMed     Abstract available
    
    
    
48. LUNDE NN, Gregersen I, Ueland T, Shetelig C, et al
    Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages.
    Atherosclerosis. 2020;296:74-82.
    PubMed     Abstract available
    
    
    
49. GUARALDI G, Milic J, Prandini N, Ligabue G, et al
    (18)Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients.
    Atherosclerosis. 2020;297:127-135.
    PubMed     Abstract available
    
    
    
50. LIM SS, Yang YL, Chen SC, Wu CH, et al
    Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.
    Atherosclerosis. 2020;297:40-46.
    PubMed     Abstract available
    
    
    
51. THEN C, Then HL, Lechner A, Thorand B, et al
    Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study.
    Atherosclerosis. 2020;297:1-7.
    PubMed     Abstract available
    
    
    February 2020
52. SANTOS RD
    Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality: Can the power of zero be expanded beyond the vessels?
    Atherosclerosis. 2020;294:44-45.
    PubMed    
    
    
    
53. MIRBOLOUK M, Kianoush S, Dardari Z, Miedema MD, et al
    The association of coronary artery calcium score and mortality risk among smokers: The coronary artery calcium consortium.
    Atherosclerosis. 2020;294:33-40.
    PubMed     Abstract available
    
    
    
54. MUSCOGIURI G, Chiesa M, Trotta M, Gatti M, et al
    Performance of a deep learning algorithm for the evaluation of CAD-RADS classification with CCTA.
    Atherosclerosis. 2020;294:25-32.
    PubMed     Abstract available
    
    
    
55. BLAHA MJ, Cainzos-Achirica M, Dardari Z, Blankstein R, et al
    All-cause and cause-specific mortality in individuals with zero and minimal coronary artery calcium: A long-term, competing risk analysis in the Coronary Artery Calcium Consortium.
    Atherosclerosis. 2020;294:72-79.
    PubMed     Abstract available
    
    
    January 2020
56. PU X, Chan K, Yang W, Xiao Q, et al
    Effect of a coronary-heart-disease-associated variant of ADAMTS7 on endothelial cell angiogenesis.
    Atherosclerosis. 2020;296:11-17.
    PubMed     Abstract available
    
    
    
57. CHICHAREON P, Modolo R, Kogame N, Takahashi K, et al
    Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study.
    Atherosclerosis. 2020;295:45-53.
    PubMed     Abstract available
    
    
    
58. BONELLO-PALOT N, Laine M, Cuisset T, Ronchard T, et al
    High prevalence of mutations in perilipin 1 in patients with precocious acute coronary syndrome.
    Atherosclerosis. 2020;293:86-91.
    PubMed     Abstract available
    
    
    
59. ALKHALIL M
    Effects of intensive lipid-lowering therapy on mortality after coronary bypass surgery: A meta-analysis of 7 randomised trials.
    Atherosclerosis. 2020;293:75-78.
    PubMed     Abstract available
    
    
    
60. LEIHERER A, Ebner J, Muendlein A, Brandtner EM, et al
    High betatrophin in coronary patients protects from cardiovascular events.
    Atherosclerosis. 2020;293:62-68.
    PubMed     Abstract available
    
    
    
61. UELAND T, Akerblom A, Ghukasyan T, Michelsen AE, et al
    ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial.
    Atherosclerosis. 2020;293:35-41.
    PubMed     Abstract available
    
    
    
62. LEE JG, Ko J, Hae H, Kang SJ, et al
    Intravascular ultrasound-based machine learning for predicting fractional flow reserve in intermediate coronary artery lesions.
    Atherosclerosis. 2020;292:171-177.
    PubMed     Abstract available
    
    
    
63. KIMURA S, Sugiyama T, Hishikari K, Nakagama S, et al
    Relationship of systemic pentraxin-3 values with coronary plaque components on optical coherence tomography and post-percutaneous coronary intervention outcomes in patients with stable angina pectoris.
    Atherosclerosis. 2020;292:127-135.
    PubMed     Abstract available
    
    
    
64. MUNOZ-TORRERO JFS, Zamorano J, Rico-Martin S, Rivas MD, et al
    Proton pump inhibitors and risk for recurrent ischemic events or death in outpatients with symptomatic artery disease.
    Atherosclerosis. 2020;292:84-89.
    PubMed     Abstract available
    
    
    
65. MANCIO J, Barros AS, Conceicao G, Pessoa-Amorim G, et al
    Epicardial adipose tissue volume and annexin A2/fetuin-A signalling are linked to coronary calcification in advanced coronary artery disease: Computed tomography and proteomic biomarkers from the EPICHEART study.
    Atherosclerosis. 2020;292:75-83.
    PubMed     Abstract available
    
    
    
66. COUSELO-SEIJAS M, Agra-Bermejo RM, Fernandez AL, Martinez-Cereijo JM, et al
    High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment.
    Atherosclerosis. 2020;292:60-69.
    PubMed     Abstract available
    
    
    
67. SANDESARA PB, Mehta A, O'Neal WT, Kelli HM, et al
    Clinical significance of zero coronary artery calcium in individuals with LDL cholesterol >/=190mg/dL: The Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2020;292:224-229.
    PubMed     Abstract available
    
    
    December 2019
68. REYES C, Pons NA, Renones CR, Gallisa JB, et al
    Association between serum ferritin and acute coronary heart disease: A population-based cohort study.
    Atherosclerosis. 2019;293:69-74.
    PubMed     Abstract available
    
    
    
69. OHUKAINEN P, Kuusisto S, Kettunen J, Perola M, et al
    Data-driven multivariate population subgrouping via lipoprotein phenotypes versus apolipoprotein B in the risk assessment of coronary heart disease.
    Atherosclerosis. 2019;294:10-15.
    PubMed     Abstract available
    
    
    November 2019
70. LI W, Shu S, Cheng L, Hao X, et al
    Fasting serum total bile acid level is associated with coronary artery disease, myocardial infarction and severity of coronary lesions.
    Atherosclerosis. 2019;292:193-200.
    PubMed     Abstract available
    
    
    September 2019
71. LEON-ACUNA A, Torres-Pena JD, Alcala-Diaz JF, Vals-Delgado C, et al
    Lifestyle factors modulate postprandial hypertriglyceridemia: From the CORDIOPREV study.
    Atherosclerosis. 2019;290:118-124.
    PubMed     Abstract available
    
    
    August 2019
72. ISIOZOR NM, Kunutsor SK, Voutilainen A, Kurl S, et al
    Ideal cardiovascular health and risk of acute myocardial infarction among Finnish men.
    Atherosclerosis. 2019;289:126-131.
    PubMed     Abstract available
    
    
    
73. FANG C, Dai J, Zhang S, Wang Y, et al
    Culprit lesion morphology in young patients with ST-segment elevated myocardial infarction: A clinical, angiographic and optical coherence tomography study.
    Atherosclerosis. 2019;289:94-100.
    PubMed     Abstract available
    
    
    
74. RAMPIDIS GP, Benetos G, Benz DC, Giannopoulos AA, et al
    A guide for Gensini Score calculation.
    Atherosclerosis. 2019;287:181-183.
    PubMed    
    
    
    July 2019
75. VELLE-FORBORD T, Eidlaug M, Debik J, Saether JC, et al
    Circulating microRNAs as predictive biomarkers of myocardial infarction: Evidence from the HUNT study.
    Atherosclerosis. 2019;289:1-7.
    PubMed     Abstract available
    
    
    
76. ANHOLM C, Kumarathurai P, Pedersen LR, Samkani A, et al
    Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial.
    Atherosclerosis. 2019;288:60-66.
    PubMed     Abstract available
    
    
    June 2019
77. DYRBUS K, Gasior M, Desperak P, Osadnik T, et al
    The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals.
    Atherosclerosis. 2019;288:33-41.
    PubMed     Abstract available
    
    
    May 2019
78. KOWALL B, Stang A
    Reply to: "Methodological issues regarding "Decline in ankle-brachial index is stronger in poorly than in well controlled diabetes: Results from the Heinz Nixdorf Recall cohort study"".
    Atherosclerosis. 2019 May 4. pii: S0021-9150(19)30401.
    PubMed    
    
    
    
79. IACOBELLIS G, Mahabadi AA
    Is epicardial fat attenuation a novel marker of coronary inflammation?
    Atherosclerosis. 2019;284:212-213.
    PubMed    
    
    
    April 2019
80. DE BACKER G, Jankowski P, Kotseva K, Mirrakhimov E, et al
    Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.
    Atherosclerosis. 2019;285:135-146.
    PubMed     Abstract available
    
    
    
81. BIDHENDI YARANDI R, Panahi MH
    Methodological issues regarding "Decline in ankle-brachial index is stronger in poorly than in well controlled diabetes: Results from the Heinz Nixdorf Recall cohort study".
    Atherosclerosis. 2019 Apr 17. pii: S0021-9150(19)30382.
    PubMed    
    
    
    March 2019
82. MIRAMONTES-GONZALEZ JP, Usategui-Martin R, Perez de Isla L, Alonso R, et al
    VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia.
    Atherosclerosis. 2019;285:17-22.
    PubMed     Abstract available
    
    
    
83. RUGE T, Carlsson AC, Kjoller E, Hilden J, et al
    Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-study.
    Atherosclerosis. 2019;284:202-208.
    PubMed     Abstract available
    
    
    February 2019
84. SHIOMI M, Takeda H, Irino Y, Kimura N, et al
    Identification of novel serum markers for the progression of coronary atherosclerosis in WHHLMI rabbits, an animal model of familial hypercholesterolemia.
    Atherosclerosis. 2019;284:18-23.
    PubMed     Abstract available
    
    
    January 2019
85. PLANAS-BALLVE A, Crespo AM, Aguilar LM, Hernandez-Perez M, et al
    The Barcelona-Asymptomatic Intracranial Atherosclerosis study: Subclinical intracranial atherosclerosis as predictor of long-term vascular events.
    Atherosclerosis. 2019;282:132-136.
    PubMed     Abstract available
    
    
    
86. LIU X, Li J, Liao J, Wang H, et al
    Gpihbp1 deficiency accelerates atherosclerosis and plaque instability in diabetic Ldlr(-/-) mice.
    Atherosclerosis. 2019;282:100-109.
    PubMed     Abstract available
    
    
    
87. WADA H, Dohi T, Miyauchi K, Daida H, et al
    Reply to: "Comment on "Mean platelet volume and long-term cardiovascular outcomes in patients with stable coronary artery disease" ".
    Atherosclerosis. 2019;280:195-196.
    PubMed    
    
    
    
88. COBAN E
    Comment on "Mean platelet volume and long-term cardiovascular outcomes in patients with stable coronary artery disease".
    Atherosclerosis. 2019;280:194.
    PubMed    
    
    
    December 2018
89. SANTOS RD, Watts GF
    Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH.
    Atherosclerosis. 2018 Dec 22. pii: S0021-9150(18)31544.
    PubMed    
    
    
    
90. ZHAO Y, Evans MA, Allison MA, Bertoni AG, et al
    Multisite atherosclerosis in subjects with metabolic syndrome and diabetes and relation to cardiovascular events: The Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2018 Dec 15. pii: S0021-9150(18)31525.
    PubMed     Abstract available
    
    
    
91. SOARES AAS, Carvalho LSF, Bonilha I, Virginio VW, et al
    Adverse interaction between HDL and the mass of myocardial infarction.
    Atherosclerosis. 2018;281:9-16.
    PubMed     Abstract available
    
    
    November 2018
92. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Impact of renin-angiotensin system inhibitors on long-term clinical outcomes in patients with acute myocardial infarction treated with successful percutaneous coronary intervention with drug-eluting stents: Comparison between STEMI and NSTEMI.
    Atherosclerosis. 2018;280:166-173.
    PubMed     Abstract available
    
    
    
93. VAHAMURTO L, Pahkala K, Magnussen CG, Hutri-Kahonen N, et al
    Coronary heart disease risk factor levels in eastern and western Finland from 1980 to 2011 in the cardiovascular risk in Young Finns study.
    Atherosclerosis. 2018;280:92-98.
    PubMed     Abstract available
    
    
    
94. HUMPHRIES SE, Cooper JA, Capps N, Durrington PN, et al
    Coronary heart disease mortality in severe vs. non-severe familial hypercholesterolaemia in the Simon Broome Register.
    Atherosclerosis. 2018 Nov 12. pii: S0021-9150(18)31469.
    PubMed     Abstract available
    
    
    October 2018
95. YANG R, Song Z, Wu S, Wei Z, et al
    Toll-like receptor 4 contributes to a myofibroblast phenotype in cardiac fibroblasts and is associated with autophagy after myocardial infarction in a mouse model.
    Atherosclerosis. 2018;279:23-31.
    PubMed     Abstract available
    
    
    
96. KANURI SH, Ipe J, Kassab K, Gao H, et al
    Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarction.
    Atherosclerosis. 2018;278:232-239.
    PubMed     Abstract available
    
    
    
97. AFANASIEVA OI, Ezhov MV, Razova OA, Afanasieva MI, et al
    Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia.
    Atherosclerosis. 2018;277:477-482.
    PubMed     Abstract available
    
    
    
98. PANG J, David Marais A, Blom DJ, Brice BC, et al
    Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice.
    Atherosclerosis. 2018;277:470-476.
    PubMed     Abstract available
    
    
    
99. ALNOURI F, Athar M, Al-Allaf FA, Abduljaleel Z, et al
    Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia.
    Atherosclerosis. 2018;277:425-433.
    PubMed     Abstract available
    
    
    
100. HARADA-SHIBA M, Ako J, Arai H, Hirayama A, et al
     Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study.
     Atherosclerosis. 2018;277:362-368.
     PubMed     Abstract available
     
     
     September 2018
101. WUOPIO J, Hilden J, Bring C, Kastrup J, et al
     Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study.
     Atherosclerosis. 2018;278:97-102.
     PubMed     Abstract available
     
     
     
102. SOLBU MD, Kolset SO, Jenssen TG, Wilsgaard T, et al
     Gender differences in the association of syndecan-4 with myocardial infarction: The population-based Tromso Study.
     Atherosclerosis. 2018;278:166-173.
     PubMed     Abstract available
     
     
     
103. ALKHALIL M, Biasiolli L, Akbar N, Galassi F, et al
     T2 mapping MRI technique quantifies carotid plaque lipid, and its depletion after statin initiation, following acute myocardial infarction.
     Atherosclerosis. 2018 Sep 6. pii: S0021-9150(18)31343.
     PubMed     Abstract available
     
     
     
104. BEYAN C, Beyan E
     Mean platelet volume may not have a role in the prediction of adverse events after percutaneous coronary intervention in patients with ST elevation myocardial infarction.
     Atherosclerosis. 2018;276:204-205.
     PubMed    
     
     
     
105. WANG Y, Zhu J, Handberg A, Overvad K, et al
     Association between plasma CD36 levels and incident risk of coronary heart disease among Danish men and women.
     Atherosclerosis. 2018;277:163-168.
     PubMed     Abstract available
     
     
     August 2018
106. BYUN JK, Choi BG, Rha SW, Choi SY, et al
     Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention.
     Atherosclerosis. 2018;277:130-135.
     PubMed     Abstract available
     
     
     July 2018
107. MACHADO GP, de Araujo GN, Wainstein M
     Reply to "Mean platelet volume may not have a role in the prediction of adverse events after percutaneous coronary intervention in patients with ST-elevation myocardial infarction".
     Atherosclerosis. 2018 Jul 21. pii: S0021-9150(18)31217.
     PubMed    
     
     
     June 2018
108. SCHRODER J, Zethner-Moller R, Bove KB, Mygind ND, et al
     Protein biomarkers and coronary microvascular dilatation assessed by rubidium-82 PET in women with angina pectoris and no obstructive coronary artery disease.
     Atherosclerosis. 2018;275:319-327.
     PubMed     Abstract available
     
     
     May 2018
109. BALCER B, Dykun I, Schlosser T, Forsting M, et al
     Pericoronary fat volume but not attenuation differentiates culprit lesions in patients with myocardial infarction.
     Atherosclerosis. 2018 May 25. pii: S0021-9150(18)30278.
     PubMed     Abstract available
     
     
     
110. VENEGAS-PINO DE, Lagrotteria A, Wang PW, Morphet J, et al
     Evidence of extensive atherosclerosis, coronary artery disease and myocardial infarction in the ApoE(-/-):Ins2(+/Akita) mouse fed a western diet.
     Atherosclerosis. 2018;275:88-96.
     PubMed     Abstract available
     
     
     
111. MACHADO GP, Araujo GN, Carpes CK, Lech M, et al
     Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
     Atherosclerosis. 2018;274:212-217.
     PubMed     Abstract available
     
     
     
112. DONG SY, Yan ST, Wang ML, Li ZB, et al
     Associations of body weight and weight change with cardiovascular events and mortality in patients with coronary heart disease.
     Atherosclerosis. 2018;274:104-111.
     PubMed     Abstract available
     
     
     
113. SHEN ZX, Yang QZ, Li C, Du LJ, et al
     Myeloid peroxisome proliferator-activated receptor gamma deficiency aggravates myocardial infarction in mice.
     Atherosclerosis. 2018;274:199-205.
     PubMed     Abstract available
     
     
     
114. RAGGI P
     Angina severity, therapeutic choices and outcome in patients with diabetes mellitus.
     Atherosclerosis. 2018 May 3. pii: S0021-9150(18)30223.
     PubMed    
     
     
     
115. HUMPHRIES SE, Cooper JA, Seed M, Capps N, et al
     Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.
     Atherosclerosis. 2018;274:41-46.
     PubMed     Abstract available
     
     
     April 2018
116. WILCOX T, Newman JD, Maldonado TS, Rockman C, et al
     Peripheral vascular disease risk in diabetic individuals without coronary heart disease.
     Atherosclerosis. 2018 Apr 30. pii: S0021-9150(18)30211.
     PubMed     Abstract available
     
     
     
117. LAVIN B, Protti A, Lorrio S, Dong X, et al
     MRI with gadofosveset: A potential marker for permeability in myocardial infarction.
     Atherosclerosis. 2018 Apr 25. pii: S0021-9150(18)30209.
     PubMed     Abstract available
     
     
     March 2018
118. DHAR I, Lysne V, Seifert R, Svingen GFT, et al
     Plasma methionine and risk of acute myocardial infarction: Effect modification by established risk factors.
     Atherosclerosis. 2018;272:175-181.
     PubMed     Abstract available
     
     
     
119. WILLIAMS BA, Chagin KM, Bash LD, Boden WE, et al
     External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction.
     Atherosclerosis. 2018;272:80-86.
     PubMed     Abstract available
     
     
     
120. CARLSSON AC, Jansson JH, Soderberg S, Ruge T, et al
     Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern Sweden.
     Atherosclerosis. 2018;272:41-46.
     PubMed     Abstract available
     
     
     February 2018
121. RAGGI P
     Atherosclerosis imaging to refine cardiovascular risk assessment in diabetic patients: Computed tomography and positron emission tomography applications.
     Atherosclerosis. 2018;271:77-83.
     PubMed     Abstract available
     
     
     
122. YIN H, Pickering JG
     Aortic smooth muscle cells and myocardial infarction: Does the ascending aorta feel a heart attack?
     Atherosclerosis. 2018 Feb 10. pii: S0021-9150(18)30080.
     PubMed    
     
     
     January 2018
123. PELCZARSKA A, Jakubczyk M, Jakubiak-Lasocka J, Banach M, et al
     The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland.
     Atherosclerosis. 2018;270:132-138.
     PubMed     Abstract available
     
     
     
124. MARACLE CX, Agca R, Helder B, Meeuwsen JAL, et al
     Noncanonical NF-kappaB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction.
     Atherosclerosis. 2018;270:33-41.
     PubMed     Abstract available
     
     
     
125. WONGSURAWAT T, Woo CC, Giannakakis A, Lin XY, et al
     Distinctive molecular signature and activated signaling pathways in aortic smooth muscle cells of patients with myocardial infarction.
     Atherosclerosis. 2018 Jan 29. pii: S0021-9150(18)30024.
     PubMed     Abstract available
     
     
     
126. MULE G, Vadala M, Geraci G, Cottone S, et al
     Retinal vascular imaging in cardiovascular medicine: New tools for an old examination.
     Atherosclerosis. 2018;268:188-190.
     PubMed    
     
     
     December 2017
127. HAMAZAKI K, Iso H, Eshak ES, Ikehara S, et al
     Plasma levels of n-3 fatty acids and risk of coronary heart disease among Japanese: The Japan Public Health Center-based (JPHC) study.
     Atherosclerosis. 2017 Dec 8. pii: S0021-9150(17)31423.
     PubMed     Abstract available
     
     
     
128. NISHIHIRA K, Shibata Y, Yamashita A, Kuriyama N, et al
     Relationship between thrombus age in aspirated coronary material and mid-term major adverse cardiac and cerebrovascular events in patients with acute myocardial infarction.
     Atherosclerosis. 2017;268:138-144.
     PubMed     Abstract available
     
     
     October 2017
129. ERCAN E
     Statin treatment in dialysis patients after acute myocardial infarction improves overall mortality.
     Atherosclerosis. 2017 Oct 23. pii: S0021-9150(17)31348.
     PubMed     Abstract available
     
     
     September 2017
130. CHUNG CM, Lin MS, Chang CH, Cheng HW, et al
     Moderate to high intensity statin in dialysis patients after acute myocardial infarction: A national cohort study in Asia.
     Atherosclerosis. 2017 Sep 27. pii: S0021-9150(17)31288.
     PubMed     Abstract available
     
     
     
131. POKHAREL Y, Sharma PP, Qintar M, Lu Y, et al
     High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction.
     Atherosclerosis. 2017;266:16-23.
     PubMed     Abstract available
     
     
     
132. SAITO I, Yamagishi K, Kokubo Y, Yatsuya H, et al
     Association of high-density lipoprotein cholesterol concentration with different types of stroke and coronary heart disease: The Japan Public Health Center-based prospective (JPHC) study.
     Atherosclerosis. 2017;265:147-154.
     PubMed     Abstract available
     
     
     August 2017
133. GITT AK, Lautsch D, Ferrieres J, De Ferrari GM, et al
     Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
     Atherosclerosis. 2017;266:158-166.
     PubMed     Abstract available
     
     
     
134. ATTARD R, Dingli P, Doggen CJM, Cassar K, et al
     The independent effect of helicobacter pylori infection and elevated gastrin levels on the risk of myocardial infarction.
     Atherosclerosis. 2017;263:e96-e97.
     PubMed    
     
     
     
135. WOO CC, Wongsurawat T, Soong R, Lee CN, et al
     Distinctive pattern of LET-7B and MIR-30B in human aortic smooth muscle cells of myocardial infarction patients.
     Atherosclerosis. 2017;263:e63.
     PubMed    
     
     
     
136. KIM TH, Kang K, Kim EM, Park HE, et al
     Mesenchymal stem cells promote the infiltration of myeloid derived suppressor cells in a mouse myocardial infarction model.
     Atherosclerosis. 2017;263:e60.
     PubMed    
     
     
     
137. KURDI A, De Meyer GRY, Martinet W
     Everolimus attenuates atherosclerotic plaque progression, intraplaque neovascularization, myocardial infarction and sudden death in a mouse model of advanced atherosclerosis.
     Atherosclerosis. 2017;263:e59.
     PubMed    
     
     
     
138. DOULAMIS I, Tzani A, Konstantopoulos P, Gkogkos A, et al
     Sirtuin-1 and MMP-2 levels in patients with advanced coronary artery disease: A combined index for incidence of myocardial infarction.
     Atherosclerosis. 2017;263:e53.
     PubMed    
     
     
     
139. RYAZANKINA N, Manchurov V, Vasilieva E, Shpektor A, et al
     Improved in-hospital clinical outcomes in patients with acute ST-elevation myocardial infarction undergoing remote ischemic preconditioning before primary percutaneous coronary intervention.
     Atherosclerosis. 2017;263:e49-e50.
     PubMed    
     
     
     
140. MARINKOVIC G, Winkler L, Kefene L, Nilsson J, et al
     The alarmin complex S100A8/9 as a potential therapeutic target after myocardial infarction.
     Atherosclerosis. 2017;263:e48-e49.
     PubMed    
     
     
     
141. PFETSCH V, Sanin V, Jaensch A, Dallmeier D, et al
     Increased concentrations of soluble ST2 independently predict cardiac and total mortality but not non-fatal cardiovascular events in stable coronary heart disease patients.
     Atherosclerosis. 2017;263:e46-e47.
     PubMed    
     
     
     
142. ANTIOCHOS P, Marques-Vidal P, Virzi J, Pagano S, et al
     Impact of CD14 polymorphisms on anti-apolipoprotein A-1 IGG-related coronary heart disease prediction in the general population.
     Atherosclerosis. 2017;263:e45.
     PubMed    
     
     
     
143. PECHERINA T, Kashtalap V, Barbarash O
     Effects of statins on inflammatory markers and matrix metalloproteinases in patients with ST-segment elevation myocardial infarction.
     Atherosclerosis. 2017;263:e45-e46.
     PubMed    
     
     
     
144. BOUZID K, Ben Ahmed H, Boussaid H, Kamoun M, et al
     Relationship between galectin-3 levels in ST elevation myocardial infarction and the burden of atherosclerosis.
     Atherosclerosis. 2017;263:e275.
     PubMed    
     
     
     
145. NIZOMOV A, Kenjaev S
     Effect of high-dose atorvastatin on lipid spectrum and inflammation in acute myocardial infarction.
     Atherosclerosis. 2017;263:e245-e246.
     PubMed    
     
     
     
146. AZIZ N, Sirojiddin K, Majid K
     Influence of high doses of atorvastatin on myocardial stanning in acute myocardial infarction.
     Atherosclerosis. 2017;263:e245.
     PubMed    
     
     
     
147. GRAESDAL A, Dybvig A
     Lipoprotein apheresis as a treatment modality for familial combined hyperlipidemia (FCH) with non-alcoholic fatty liver disease (NAFLD) and coronary heart disease: a casuistic approach.
     Atherosclerosis. 2017;263:e243-e244.
     PubMed    
     
     
     
148. BATURINA O, Mironova O
     Clinical case of hyperlipidemia type IV in a man with diabetes, myocardial infarction and stroke.
     Atherosclerosis. 2017;263:e227-e228.
     PubMed    
     
     
     
149. REVNIC CR, Revnic F, Pena C, Nica AS, et al
     Biochemical studies of atherogenic potential of serum from patients with unstable angina coronary atherosclerosis.
     Atherosclerosis. 2017;263:e219-e220.
     PubMed    
     
     
     
150. QAYYUM F, Lauridsen B, Frikke-Schmidt R, Nordestgaard B, et al
     Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
     Atherosclerosis. 2017;263:e21.
     PubMed    
     
     
     
151. PAPADOPOULOS D, Grassos H, Sanidas E, Barbetseas J, et al
     Triglyceride blood levels and metalloproteinases activity in acute myocardial infarction patients.
     Atherosclerosis. 2017;263:e203.
     PubMed    
     
     
     
152. FEDOROVA N, Kashtalap V, Barbarash O
     Galectin-3 levels in patients with ST segment elevation myocardial infarction.
     Atherosclerosis. 2017;263:e199.
     PubMed    
     
     
     
153. PECHERINA T, Kashtalap V, Barbarash O, Zhuravleva E, et al
     The value of matrix metalloproteinases in coronary atherosclerosis progression in patients after ST-segment elevation myocardial infarction in one year.
     Atherosclerosis. 2017;263:e198.
     PubMed    
     
     
     
154. ZIVOTIC I, Zivkovic M, Djuric T, Stankovic A, et al
     Rs10757278 from 9p21 is associated with ST-elevated myocardial infarction in females in population of Serbia.
     Atherosclerosis. 2017;263:e188.
     PubMed    
     
     
     
155. FARES AL, Hussein El Bacha AA, Souza CS, Garcia De Carvalho JA, et al
     High prevalence of familial hypercholesterolemia in patients with coronary heart disease at a Brazilian quaternary healthcare center.
     Atherosclerosis. 2017;263:e181-e183.
     PubMed    
     
     
     
156. DJORDJEVIC A, Zivkovic M, Dekleva M, Markovic-Nikolic N, et al
     SNPS in the vicinity of LGALS-3 locus and different shape-types of heart remodeling after the first myocardial infarction: Preliminary results.
     Atherosclerosis. 2017;263:e180.
     PubMed    
     
     
     
157. NUSSBAUMEROVA B, Rosolova H, Mayer O Jr, Filipovsky J, et al
     Residual cardiovascular risk in patients with stable coronary heart disease over the last 16 years (Czech part of the EUROASPIRE I-IV surveys).
     Atherosclerosis. 2017;263:e177.
     PubMed    
     
     
     
158. KASHTALAP V, Barbarash O, Gorbunova E, Sedyh D, et al
     Psychophysiological personality characteristics of patients with recurrent myocardial infarction.
     Atherosclerosis. 2017;263:e174.
     PubMed    
     
     
     
159. IGNATEVA O, Berkovich O, Volkova E, Moroshkina N, et al
     S19W polymorphism of apo AV is an independent risk factor for myocardial infarction among young men.
     Atherosclerosis. 2017;263:e173-e174.
     PubMed    
     
     
     
160. DIAZ-PEROMINGO JA, Macia-Rodriguez C, Alende-Castro V, Paez-Guillan E, et al
     Comorbidity and sex differences among patients with ischemic heart disease currently smokers.
     Atherosclerosis. 2017;263:e172.
     PubMed    
     
     
     
161. KECHIDA M, Jomaa W, Hamda KB, Klii R, et al
     Myocardial infarction as a first symptom of activated protein C resistance associated to hyperhomocyteinemia.
     Atherosclerosis. 2017;263:e162.
     PubMed    
     
     
     
162. NIZOMOV A, Kenjaev M, Kenjaev S, Kenjaev S, et al
     The relationship between the parameters of longitudinal systolic function and left ventricular remodeling in patients with acute myocardial infarction.
     Atherosclerosis. 2017;263:e159.
     PubMed    
     
     
     
163. HONG TJ, Lee HW, Choi JH, Choi JC, et al
     Comparison of long term clinical outcomes between bare metal stent versus different types of drug eluting stents for treatment of acute myocardial infarction.
     Atherosclerosis. 2017;263:e155-e156.
     PubMed    
     
     
     
164. SHALAEVA A, Dadabaeva N
     Compliance initiatives in management of patients with coronary artery disease after acute myocardial infarction.
     Atherosclerosis. 2017;263:e152-e153.
     PubMed    
     
     
     
165. SHAH N, Meira L, Elliott R, Bordin D, et al
     DNA repair measuring DNA ligase activity in non ST-elevation myocardial infarction determines atherosclerotic plaque instability.
     Atherosclerosis. 2017;263:e143.
     PubMed    
     
     
     
166. SHAH N, Meira L, Forrer-Charlier C, Mahmoudi M, et al
     Up-regulation of base excision repair gene 8-oxoguanine glycosylase 1 expression in non ST-elevation myocardial infarction and correlation with atherosclerotic fibrous cap thickness.
     Atherosclerosis. 2017;263:e142-e143.
     PubMed    
     
     
     
167. ROMANOVA V
     Condition of adhesive endothelial function in coronary heart disease patients.
     Atherosclerosis. 2017;263:e141.
     PubMed    
     
     
     
168. DUMITRIU IE, Bulenkamp J, Chhetri I
     Homeostatic cytokines interleukin-7 (IL-7) and IL-15 drive the expansion and activation of CD4+CD28null t cells in patients with myocardial infarction.
     Atherosclerosis. 2017;263:e14-e15.
     PubMed    
     
     
     
169. NIZOMOV A, Kenjaev S, Kenjaev M, Mukhamedova M, et al
     Dynamics of indicators of longitudinal left ventricular systolic function in patients with acute myocardial infarction during stress echocardiography with dobutamine.
     Atherosclerosis. 2017;263:e122.
     PubMed    
     
     
     
170. MUSIKHINA N, Petelina T, Gapon L, Emeneva I, et al
     Peculiarity of vascular inflammatory response in patients with unstable angina.
     Atherosclerosis. 2017;263:e118.
     PubMed    
     
     
     
171. VERWEIJ S, Delewi R, Stiekema L, Versloot M, et al
     Prolonged inflammatory state after myocardial infarction.
     Atherosclerosis. 2017;263:e117-e118.
     PubMed    
     
     
     
172. KUMAR V
     Demonstrating the decline in coronary heart disease mortality in the Central Delhi, India between 2010 to 2015.
     Atherosclerosis. 2017;263:e110.
     PubMed    
     
     
     
173. DE GONZALO CALVO D, Sanchez Vega J, Vilades D, Nasarre L, et al
     Diagnostic value of circulating miRNAs: Association with the presence and extension of coronary atherosclerosis in patients with suspected ischemic heart disease.
     Atherosclerosis. 2017;263:e106.
     PubMed    
     
     
     July 2017
174. AGARWALA A, Pokharel Y, Saeed A, Sun W, et al
     The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.
     Atherosclerosis. 2017;262:131-137.
     PubMed     Abstract available
     
     
     
175. HOLMLUND A, Lampa E, Lind L
     Oral health and cardiovascular disease risk in a cohort of periodontitis patients.
     Atherosclerosis. 2017;262:101-106.
     PubMed     Abstract available
     
     
     
176. CHUNG RWS, Leanderson P, Lundberg AK, Jonasson L, et al
     Lutein exerts anti-inflammatory effects in patients with coronary artery disease.
     Atherosclerosis. 2017;262:87-93.
     PubMed     Abstract available
     
     
     
177. TOUTOUZAS K, Benetos G, Koutagiar I, Barampoutis N, et al
     Noninvasive detection of increased carotid artery temperature in patients with coronary artery disease predicts major cardiovascular events at one year: Results from a prospective multicenter study.
     Atherosclerosis. 2017;262:25-30.
     PubMed     Abstract available
     
     
     
178. ZHANG Q, Wang A, Zhang S, Li N, et al
     Asymptomatic polyvascular disease and the risks of cardiovascular events and all-cause death.
     Atherosclerosis. 2017;262:1-7.
     PubMed     Abstract available
     
     
     
179. CHO I, O Hartaigh B, Gransar H, Valenti V, et al
     Prognostic implications of coronary artery calcium in the absence of coronary artery luminal narrowing.
     Atherosclerosis. 2017;262:185-190.
     PubMed     Abstract available
     
     
     June 2017
180. VONGPROMEK R, Bos S, Ten Kate GR, Bujo H, et al
     Soluble LR11 associates with aortic root calcification in asymptomatic treated male patients with familial hypercholesterolemia.
     Atherosclerosis. 2017 Jun 9. pii: S0021-9150(17)30268.
     PubMed     Abstract available
     
     
     
181. FAIROOZY RH, Cooper J, White J, Giambartolomei C, et al
     Identifying low density lipoprotein cholesterol associated variants in the Annexin A2 (ANXA2) gene.
     Atherosclerosis. 2017;261:60-68.
     PubMed     Abstract available
     
     
     
182. WANG A, Kwee LC, Grass E, Neely ML, et al
     Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome.
     Atherosclerosis. 2017;261:19-25.
     PubMed     Abstract available
     
     
     
183. NAKAJIMA S, Ito H, Mitsuhashi T, Kubo Y, et al
     Clinical application of effective atomic number for classifying non-calcified coronary plaques by dual-energy computed tomography.
     Atherosclerosis. 2017;261:138-143.
     PubMed     Abstract available
     
     
     
184. TADA H, Kawashiri MA, Sakata K, Yoneda T, et al
     Renal glucosuria is not associated with atherosclerotic cardiovascular disease outcome in a general Japanese community.
     Atherosclerosis. 2017;261:111-116.
     PubMed     Abstract available
     
     
     May 2017
185. SHARIFI M, Higginson E, Bos S, Gallivan A, et al
     Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.
     Atherosclerosis. 2017 May 13. pii: S0021-9150(17)30218.
     PubMed     Abstract available
     
     
     
186. GLEISSNER CA, Erbel C, Linden F, Domschke G, et al
     Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: Insights from the LURIC study.
     Atherosclerosis. 2017;260:121-129.
     PubMed     Abstract available
     
     
     
187. VERDOIA M, Nardin M, Rolla R, Marino P, et al
     Immature platelet fraction and the extent of coronary artery disease: A single centre study.
     Atherosclerosis. 2017;260:110-115.
     PubMed     Abstract available
     
     
     
188. PANH L, Ruidavets JB, Rousseau H, Petermann A, et al
     Association between serum alkaline phosphatase and coronary artery calcification in a sample of primary cardiovascular prevention patients.
     Atherosclerosis. 2017;260:81-86.
     PubMed     Abstract available
     
     
     
189. BASKARAN L, O Hartaigh B, Schulman-Marcus J, Gransar H, et al
     Dense calcium and lesion-specific ischemia: A comparison of CCTA with fractional flow reserve.
     Atherosclerosis. 2017;260:163-168.
     PubMed     Abstract available
     
     
     April 2017
190. MANGILI LC, Miname MH, Silva PRS, Bittencourt MS, et al
     Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study.
     Atherosclerosis. 2017 Apr 30. pii: S0021-9150(17)30189.
     PubMed     Abstract available
     
     
     
191. KITAHARA H, Waseda K, Sakamoto K, Yamada R, et al
     Impact of attenuated-signal plaque observed by intravascular ultrasound on vessel response after drug-eluting stent implantation.
     Atherosclerosis. 2017;259:68-74.
     PubMed     Abstract available
     
     
     March 2017
192. LI S, Wu NQ, Zhu CG, Zhang Y, et al
     Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
     Atherosclerosis. 2017;260:67-74.
     PubMed     Abstract available
     
     
     
193. KITAGAWA K, Amano T, Uetani T, Ishii H, et al
     Association between plaque characteristics and the amount of debris captured by a filter-type distal protection device in patients with acute coronary syndrome.
     Atherosclerosis. 2017;258:72-78.
     PubMed     Abstract available
     
     
     
194. KWON CH, Kang JG, Lee HJ, Kim NH, et al
     Absence of association between gallstone and coronary artery calcification.
     Atherosclerosis. 2017;258:51-55.
     PubMed     Abstract available
     
     
     
195. RIZVI A, Hartaigh BO, Danad I, Han D, et al
     Diffuse coronary artery disease among other atherosclerotic plaque characteristics by coronary computed tomography angiography for predicting coronary vessel-specific ischemia by fractional flow reserve.
     Atherosclerosis. 2017;258:145-151.
     PubMed     Abstract available
     
     
     
196. ABD-ELMONIEM KZ, Ramos N, Yazdani SK, Ghanem AM, et al
     Coronary atherosclerosis and dilation in hyper IgE syndrome patients: Depiction by magnetic resonance vessel wall imaging and pathological correlation.
     Atherosclerosis. 2017;258:20-25.
     PubMed     Abstract available
     
     
     
197. SHAHID SU, Shabana, Cooper JA, Beaney KE, et al
     Genetic risk analysis of coronary artery disease in Pakistani subjects using a genetic risk score of 21 variants.
     Atherosclerosis. 2017;258:1-7.
     PubMed     Abstract available
     
     
     
198. CAMPOS AM, Moura FA, Santos SN, Freitas WM, et al
     Sarcopenia, but not excess weight or increased caloric intake, is associated with coronary subclinical atherosclerosis in the very elderly.
     Atherosclerosis. 2017;258:138-144.
     PubMed     Abstract available
     
     
     
199. MADSEN DM, Diederichsen ACP, Hosbond SE, Gerke O, et al
     Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
     Atherosclerosis. 2017;258:131-137.
     PubMed     Abstract available
     
     
     February 2017
200. CHRISTIANSEN MK, Nyegaard M, Pedersen LN, Larsen SB, et al
     A 45-SNP genetic risk score is increased in early-onset coronary artery disease but independent of familial disease clustering.
     Atherosclerosis. 2017;257:172-178.
     PubMed     Abstract available
     
     
     
201. OSAWA K, Nakanishi R, Budoff MJ
     Is there a role for coronary artery calcification scoring in primary prevention of cerebrovascular disease?
     Atherosclerosis. 2017;257:279-287.
     PubMed     Abstract available
     
     
     
202. LIN JF, Wu S, Juang JJ, Chiang FT, et al
     IL1RL1 single nucleotide polymorphism predicts sST2 level and mortality in coronary and peripheral artery disease.
     Atherosclerosis. 2017;257:71-77.
     PubMed     Abstract available
     
     
     
203. DE VRIES MA, Trompet S, Mooijaart SP, Smit RA, et al
     Complement receptor 1 gene polymorphisms are associated with cardiovascular risk.
     Atherosclerosis. 2017;257:16-21.
     PubMed     Abstract available
     
     
     
204. KIM J, Budoff MJ, Nasir K, Wong ND, et al
     Thoracic aortic calcium, cardiovascular disease events, and all-cause mortality in asymptomatic individuals with zero coronary calcium: The Multi-Ethnic Study of Atherosclerosis (MESA).
     Atherosclerosis. 2017;257:1-8.
     PubMed     Abstract available
     
     
     
205. LEE EM, Choi MH, Seo HS, Kim HK, et al
     Impact of vasomotion type on prognosis of coronary artery spasm induced by acetylcholine provocation test of left coronary artery.
     Atherosclerosis. 2017;257:195-200.
     PubMed     Abstract available
     
     
     
206. CHEEZUM MK, Kim A, Bittencourt MS, Kassop D, et al
     Association of tobacco use and cessation with coronary atherosclerosis.
     Atherosclerosis. 2017;257:201-207.
     PubMed     Abstract available
     
     
     January 2017
207. MAILE LA, Busby WH, Xi G, Gollahan KP, et al
     An anti-alphaVbeta3 antibody inhibits coronary artery atherosclerosis in diabetic pigs.
     Atherosclerosis. 2017;258:40-50.
     PubMed     Abstract available
     
     
     
208. WIDHALM K, Benke IM, Fritz M, Geiger H, et al
     Homozygous familial hypercholesterolemia: Summarized case reports.
     Atherosclerosis. 2017;257:86-89.
     PubMed     Abstract available
     
     
     
209. BRUCKERT E, Kalmykova O, Bittar R, Carreau V, et al
     Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.
     Atherosclerosis. 2017;257:130-137.
     PubMed     Abstract available
     
     
     
210. BOS S, Duvekot MH, Ten Kate GR, Verhoeven AJ, et al
     Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study.
     Atherosclerosis. 2017;256:62-66.
     PubMed     Abstract available
     
     
     
211. NONIN S, Iwata S, Sugioka K, Fujita S, et al
     Plaque surface irregularity and calcification length within carotid plaque predict secondary events in patients with coronary artery disease.
     Atherosclerosis. 2017;256:29-34.
     PubMed     Abstract available
     
     
     December 2016
212. LEE DH, Chun EJ, Hur JH, Min SH, et al
     Effect of sarpogrelate, a selective 5-HT2A receptor antagonist, on characteristics of coronary artery disease in patients with type 2 diabetes.
     Atherosclerosis. 2016;257:47-54.
     PubMed     Abstract available
     
     
     November 2016
213. SCICALI R, Giral P, Gallo A, Di Pino A, et al
     HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients.
     Atherosclerosis. 2016;255:102-108.
     PubMed     Abstract available
     
     
     
214. NAKANISHI R, Ceponiene I, Osawa K, Luo Y, et al
     Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study.
     Atherosclerosis. 2016;255:73-79.
     PubMed     Abstract available
     
     
     October 2016
215. OGURA M, Makino H, Kamiya C, Yoshimatsu J, et al
     Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion.
     Atherosclerosis. 2016;254:179-183.
     PubMed     Abstract available
     
     
     September 2016
216. MANGILI LC, Mangili OC, Bittencourt MS, Miname MH, et al
     Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia.
     Atherosclerosis. 2016;254:73-77.
     PubMed     Abstract available
     
     
     August 2016
217. ALONSO R, Mata P, Muniz O, Fuentes-Jimenez F, et al
     PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.
     Atherosclerosis. 2016 Aug 27. pii: S0021-9150(16)31306.
     PubMed     Abstract available
     
     
     
218. IKEDA N, Hara H, Hiroi Y, Nakamura M, et al
     Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events in non-diabetic patients without coronary artery disease.
     Atherosclerosis. 2016;253:1-6.
     PubMed     Abstract available
     
     
     July 2016
219. WATTS GF, Pang J, Chan DC, Brunt JN, et al
     Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resin.
     Atherosclerosis. 2016;252:82-87.
     PubMed     Abstract available
     
     
     May 2016
220. NARDIN M, Verdoia M, Schaffer A, Barbieri L, et al
     Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography.
     Atherosclerosis. 2016;250:114-121.
     PubMed     Abstract available
     
     
     
221. MENEGAUT L, Masson D, Abello N, Denimal D, et al
     Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients.
     Atherosclerosis. 2016 May 4. pii: S0021-9150(16)30164.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: